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Abstract
Background: Staphylococcus aureus is the major cause of global and nosocomial infections with a significant impact in
hospitals worldwide. Our objective was to investigate clinical and molecular characteristics of S. aureus isolates causing
infections in patients admitted to hospitals from Recife city, Brazil, and investigate the prevalence of oxacillin-susceptible
mecA-positive S. aureus (OS-MRSA) in the region, as well as genetically characterize the isolates and compare with
epidemic clones.
Results: We characterized 89 isolates in total, 31 clinical methicillin-resistant S. aureus (MRSA) and 58 methicillin-sensitive
(MSSA) isolates by PFGE, MLST, spa typing and SCCmec genotyping. Isolates belonging to international MRSA clones
were present: Brazilian epidemic clone (BEC) (61 % of MRSA isolates), Paediatric (36 %), New York/Japan (3 %). Some
MSSA isolates were related to MRSA clones: USA400-related (10 % of MSSA isolates), Berlin clone (2 %), Paediatric (14 %),
New York/Japan (2 %) and Southwest Pacific clone (17 %). MLST revealed new sequence types (ST’s): ST2381, ST2382,
and ST2383 and new spa types: 10548 and 10550. Among isolates phenotypically identified as MSSA by antimicrobial
susceptibility assays, we verified 30 oxacillin-susceptible isolates, which exhibited the mecA gene, without mec complex
amplification and were thus classified as OS-MRSA. We observed clonal spread of MRSA and MSSA, including OS-MRSA,
within several areas of the main hospital investigated and closely related isolates between hospitals analyzed.
Conclusions: The results of this study suggest a possible spread of the strains in hospital environment that could be
responsible for nosocomial infections. We documented the presence of several MRSA clones, as well as new MLST and
spa types, that were responsible for severe infections in hospitalized patients. The finding of OS-MRSA isolates could
have implications for therapy, because testing for mecA and PBP2a is not a routine procedure performed by clinical
microbiology laboratories in Brazil and, as consequence, these isolates could be misclassified as MSSA. Our data alert to
the necessity to develop more effective strategies for epidemiological control of S. aureus in order to avoid an increase
of hospital infections provoked by this pathogen. We reinforce the use of genetic methods, in addition to phenotypic
tests, for a precise identification of MRSA.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA) has
become widespread in hospitals, causing both serious
nosocomial and community-associated infections world-
wide. However, methicillin-sensitive S. aureus (MSSA),
which generally is genetically more diverse than MRSA,
remains an important cause of infection [1, 2].
Methicillin-resistance in S. aureus results from acquisi-
tion of the mecA gene, harbored on a mobile genetic
element (MGE), staphylococcal cassette chromosome
(SCCmec), which produces an alternative penicillin-binding
protein (PBP2a) with a low affinity for β-lactam antibiotics
[2, 3]. Hospital-associated (HA)-MRSA isolates usually
carry SCCmecI, II, or III, whereas community-associated
(CA)-MRSA strains commonly carry SCCmecIV, and less
frequently, SCCmecV or VII [3, 4]. MRSA has been defined
as S. aureus having the mecA gene or phenotypically show-
ing resistance to oxacillin/cefoxitin. However, some isolates
carry the mecA gene but are susceptible to oxacillin/cefoxi-
tin, referred to as oxacillin-susceptible MRSA (OS-MRSA),
also known as cefoxitin-sensitive MRSA, which have been
reported worldwide [5–8].
MRSA accounted for 54 % of nosocomial S. aureus
infections in Brazil in 2006 [9]. A multiresistant HA-
MRSA clone, known as Brazilian epidemic clone (BEC),
characterized as sequence type (ST) 239 and SCCmecIII,
is responsible for the majority of nosocomial infections in
Brazil [10–12]. However, more recent studies reported a
frequent occurrence of the MRSA USA800/Paediatric
clone (PC) (ST5-SCCmecIV), USA100/New York/Japan
clone (ST5-SCCmecII), USA400 (ST1-SCCmecIV) and
USA1100/Southwest pacific clone (SWP) (ST30-SCCme-
cIV) in Brazilian hospitals [13–18].
The aim of this study was to investigate clinical and
molecular characteristics of S. aureus isolates that cause
infections in patients admitted to hospitals from Recife
city, Brazil, and investigate the prevalence of oxacillin-
susceptible mecA-positive S. aureus (OS-MRSA) in the
region, as well as genetically characterize the isolates
and compare with epidemic clones. Little is known
about the prevalence of these isolates causing infections
in patients admitted to hospitals in the country, espe-
cially in Northeast region. Therefore, the results may be
helpful to warn committees of nosocomial infection con-
trol about the persistence and introduction of epidemic
clones into hospitals and to alert for the development of




The project was approved by the Oswaldo Cruz
Foundation Health Research Ethics Committee, Aggeu
Magalhães Research Center, CPqAM/Fiocruz, Brazil
(CEP: 0024.0.095.000-07) and the University of Pittsburgh
Institutional Review Board (PRO11030330). The present
study involved use of existing S. aureus isolates obtained
from the microbiology laboratory of each hospital. The
samples were obtained from the routine clinical care.
There was no contact with human subjects and no access
to personal patient information. Therefore, no informed
consent was obtained for this study. This consent proced-
ure was approved by both ethics committees.
Setting and selection of bacterial isolates
The study was conducted in Recife, a city of approxi-
mately 1.5 million inhabitants located in Pernambuco
State in Northeast Brazil and the experiments were
performed in the Infectious Diseases Epidemiology
Research Unit of the University of Pittsburgh, USA. A
total of 89 isolates of S. aureus were obtained from clinical
specimens of patients from outpatient clinics, inpatient
wards and intensive care units (ICU) of hospitals in Recife
that provide care to patients from different regions of
Pernambuco, obtained from spontaneous demand. We
collected all isolates identified as Staphylococcus aureus in
the microbiology laboratories and that were responsible
for infection in patients admitted into the hospitals. Eighty
isolates (Sa1-Sa80) were from a general university hospital
(hospital 1), collected during 2009; Four isolates (Sa82,
Sa86, Sa87, Sa89) were obtained from a second general
university hospital (hospital 2) and the remaining five
isolates (Sa81, Sa83-Sa85, Sa88) were obtained from a car-
diology hospital (hospital 3), all samples collected in 2011.
A single isolate was obtained from each patient and
reconfirmed as S. aureus by coagulase and mannitol
fermentation tests, as well as by PCR of the coagulase
gene (coa) [19]. As exclusion criteria of the study, were
not considered for analysis isolates not identified as
Staphylococcus aureus in the microbiology laboratories of
the hospitals, isolates without informations of the source
of infection and the area where the patient was admitted.
Phenotypic identification of MRSA
Antimicrobial susceptibility testing was performed by
disc diffusion method on Muller-Hinton agar (BD-
Becton, Dickinson and Company, Franklin Lakes, NJ)
according to the recommendations of the Clinical and
Laboratory Standards Institute (CLSI) [20] with the
antibiotic cefoxitin (30 μg). The plates were incubated at
35 °C with an initial reading after incubation of 24 h, and
a second reading after incubation of 48 h. The Minimum
inhibitory concentrations (MICs) of cefoxitin were deter-
mined using an E-test (bioMérieux, Lyon, France) and
using an agar dilution method with cefoxitin as preconized
by CLSI [20]. Representatives of all clusters and all
sporadic oxacillin-susceptible mecA-positive (OS-MRSA)
isolates were passaged 5 times on Muller-Hinton agar
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plates with subinhibitory concentrations of cefoxitin
(0.5 μg/ml) and then cefoxitin MICs were determined
using E-test (bioMérieux, Lyon, France). The same meth-
odology was used for the isolates before and after passages.
S. aureus ATCC 33591 and ATCC 25923 were included as
quality control strains.
Molecular characterization
Genomic DNA was extracted using the automated
NucliSens-easyMAG (bioMérieux, Durham, NC). PCR
was performed on a GeneAmp PCR System 9700
(Applied Biosystems, Foster City, CA) and Sanger
sequencing of gene loci was performed using the Big
Dye Terminator Kit v3.1 and an ABI 3730xl DNA
analyzer (Applied Biosystems, Foster City, CA).
SCCmec typing
To determine if the isolates harbored segments of
SCCmec elements I to V, identification of the SCCmec
complex was performed using two multiplex PCRs [21];
MPCR-1, that identifies five types of ccr genes (ccrAB1[1],
ccrAB2[2], ccrAB3[3], ccrAB4[4], and ccrC[5]), in which
amplification of the mecA gene was used as an internal
control; and MPCR-2 that identifies class A to class C of
mec complex [21]. The following S. aureus strains were
used as positive controls: MRSA NCTC10442 (SCCmecI,
class B mec, ccrAB1), MRSA N315 (SCCmecII, class A
mec, ccrAB2), MRSA 85/2082 (SCCmecIII, class A mec,
ccrAB3), MRSA WIS (SCCmecV, class C mec, ccrC) [21]
and MRSA1 (SCCmecIV, class B mec, ccrAB2) [22].
MLST, spa typing, and PFGE
Multilocus sequence type (MLST) was performed as previ-
ously described [23]. Analysis of chromatograms and se-
quences was performed using Lasergene’s SeqMan Pro
package (version 10.0.1, DNAStar, Madison WI). MLST se-
quences obtained were submitted to http://saureus.mlst.net
for generation of allelic profiles and to assign the sequence
type (ST). STs were assigned to a clonal complex (CC)
using eBURST (Based Upon Related Sequence Types) algo-
rithm analysis (http://eburst.mlst.net/). A CC was defined
as having at least six of seven identical loci [24].
spa typing was performed as previously described [25]
and spa types were determined using Ridom StaphType
(version 1.5.21, Ridom GmbH, Würzburg, Germany)
and the Ridom SpaServer (http://spa.ridom.de/). Using
the Based Upon Repeat Pattern (BURP) algorithm within
Ridom Staphtype software, spa types were also grouped
into spa clonal complexes (spaCC). BURP analysis
allows determination of clonal relatedness based on spa
types of S. aureus [26]. S. aureus strains MRSA1 (ST1,
t316), MRSA WIS (ST45, t123), MRSA 85/2082 (ST239,
t037), MRSA N315 (ST5, t002), MRSA NCTC10442
(ST250, t008) were used as positive controls.
Pulsed-field gel electrophoresis (PFGE) was performed
as previously described [22] on a CHEF-DR III SYSTEM
(Bio-Rad, Hercules, CA), using SmaI enzyme (30 units
per sample) [27]. The PFGE patterns were analyzed
using BioNumerics software (version 6.5, Applied Maths,
Austin, TX) and isolates were grouped into pulsed-field
types using UPGMA, >80 % relatedness with 1.5 % of
similarity tolerance and 1.5 % of Dice optimization. The
PFGE profiles were also analyzed based on the criteria of
Tenover and coworkers [27]. The clusters were compared
with the pulsed-field patterns USA100, USA300,
USA1000, USA500, USA900, USA400, USA600, USA700,
USA800, USA1100 and USA1200 [22]. The reference
standard S. aureus NRS77 was used as the global-standard
S. aureus.
Results
Genotyping and epidemiological characteristics
Staphylococcus aureus methicillin resistance (MRSA) isolates
A total of 31/89 (35 %) S. aureus were considered to be
MRSA by both antimicrobial susceptibility assays (cefox-
itin disc diffusion range to 6–12 mm of diameter and
cefoxitin MICs range of >4–128 μg/mL) and mecA gene
detection. The SCCmec typing for MRSA isolates
showed that 19/31 (61 %) isolates were SCCmec type III,
11/31 (36 %) isolates were SCCmec type IV and a single
isolate was SCCmec type II.
PFGE analysis revealed four predominant clusters
each for MRSA and MSSA isolates, designated as A-D
(Fig. 1) and E-H (Fig. 2), respectively. Some clusters in-
cluded several of the major international MRSA clones
(Clusters A/B/C included BEC; Cluster D and F,
USA800/PC; Cluster E, USA400). Only a few isolates
not included in these clusters were individually related
to epidemic clones (isolates Sa3 [USA100/New York/
Japan] and Sa32 [USA600/Berlin clone], Fig. 2, and
Sa81 [USA100], Fig. 1).
All MRSA isolates belonging to SCCmec type III were
classified as ST239 and exhibited spa type t037, being
therefore related to the BEC clone (clusters A and B,
Fig. 1). All five MRSA isolates from ICU patients in
hospital 1 were classified as related to BEC (Fig. 1, Sa47,
20, 55, 66, 36).
The 11 MRSA isolates belonging to SCCmec type IV
(Fig. 1, clusters C and D) were related to USA800/PC,
having SCCmecIV-ST5 and a PFGE pattern similar to
USA800 according to Deurenberg and Stobberingh [28].
Despite the PFGE pattern USA800 could not being
grouped into cluster C, the isolates (SCCmecIV-ST5, ex-
cept Sa1 SCCmecIV-ST2381) were most closely related
to the Pediatric Clone (USA800/PC), exhibiting no more
than 3 PFGE band difference from the USA800 pattern
by Tenover criteria [27]. Isolate Sa1 was classified as spa
type t002 and had a new MLST allele at tpi (tpi- 264),
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being designated as ST2381, which belongs to CC5. The
amplification of spa failed for 3 isolates (Sa41, Sa58 and
Sa59) and the isolates were considered as spa nontype-
able. Isolate Sa81 from the blood of a cardiology patient
from hospital 3 was related to the New York/Japan clone
(USA100) and was classified as SCCmec type II, ST105/
t002 (Fig. 1), belonged to the same clonal complex of
ST5 isolates (CC5), when analyzed by the BURST
algorithm.
Staphylococcus aureus methicillin susceptible (MSSA)
isolates
Among the 58 isolates phenotypically identified as MSSA
by antimicrobial susceptibility assays (cefoxitin disc diffu-
sion range to 25–30 mm of diameter and cefoxitin MICs
range of ≤ 4 μg/mL), there were two new ST’s (ST2382
and ST2383, Fig. 2). Isolates Sa4 and Sa8 had a previously
unknown spa type, designated as t10550, which is similar
to spa type t938. Two other isolates (Sa13 and Sa28, both
ST5), exhibited a previously-unknown spa type, classified
as t10548, which is similar to spa type t5344. Isolates Sa17
and Sa38 amplified the spa gene but sequencing was
unsuccessful.
The MSSA isolates related to USA400 were grouped
into cluster E. Two ST5 isolates (spa type t10548) and 3
ST1635 isolates (t002) from cluster F were related to the
USA800/PC, additionally, isolate Sa87 (t002) from an
ICU patient in hospital 2, Sa23 (t1277) and Sa71 (t214)
from outpatient clinic of hospital 1 also belonged to the
USA800/PC.
Fig. 1 PFGE dendrogram of 31 MRSA isolates and reference strains. OC* = Outpatient Clinic; ICU* = Intensive Care Units; OncoC* = Oncology
Center; CE* = Cardiology Emergency; NT* = nontypeable; PIPD* = Pavilion of Infectious and Parasitic Diseases; PID* = Parasitic/Infectious Disease;
ST2381* = new ST described in this study
Andrade-Figueiredo and Leal-Balbino BMC Microbiology  (2016) 16:115 Page 4 of 9
Fig. 2 PFGE dendrogram of 55 MSSA isolates and reference strains. OC* =Outpatient Clinic; ICU* = Intensive Care Units; CE* = Cardiology Emergency;
NT* = nontypeable; ST2382* and ST2383* = new ST’s described in this study; t10548* and t10550* = new spa types described in this study. Isolates that
are mecA gene positive were considered to be oxacillin-susceptible, mecA-positive S. aureus (OS-MRSA). Three MSSA isolates determined to be OS-MRSA
(Sa4, Sa9, Sa45) are not shown because they were nontypeable by PFGE
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The isolates that exhibited ST333 (Sa17, Sa60, Sa77,
Sa83 and Sa06) and one isolate ST 15 (Sa38) were
grouped into cluster G. All the ST30 isolates and a
singleton ST285 isolate were grouped into cluster H.
Despite the PFGE pattern USA1100 could not being
grouped into cluster H, the isolates were most closely re-
lated to the Southwest Pacific clone (SPW, USA1100),
exhibiting no more than 3 PFGE band difference from
the USA1100 profile by Tenover criteria [27] (Fig. 2).
Two MSSA isolates were individually related to epidemic
clones. Isolate Sa03 (ST5/t2164) was related to the
USA100/New York/Japan clone and Sa32 was related to
the USA600/Berlin clone (ST45-SCCmecIV).
Oxacillin-susceptible mecA-positive S. aureus isolates
The 58 isolates, considered MSSA by both antimicrobial
susceptibility assays, were investigated to determine if
they harbored segments of SCCmec. Twenty five (43 %)
were negative for all SCCmec genes investigated. How-
ever, 30 (52 %) isolates, cefoxitin MICs in the range of
2–4 μg/mL, were mecA gene positive, of which 15
isolates also amplified ccr genes types 2, 3 or 5, without
mec complex amplication (Fig. 2). These isolates were
thus classified as oxacillin-susceptible mecA-positive S.
aureus (OS-MRSA) and were highly diverse by MLST
and PFGE (Fig. 2). In order to confirm if OS-MRSA
isolates observed can be truly oxacillin-susceptible,
representatives of all clusters and all sporadic oxacillin-
susceptible mecA-positive isolates (Sa3, Sa14, Sa24, Sa26,
Sa34, Sa40, Sa46, Sa52, Sa61, Sa64, Sa74, Sa77, Sa80, Sa87
and Sa88) were tested with subinhibitory concentrations of
cefoxitin and cefoxitin MICs were determined. As a result,
cefoxitin MICs, before passages, range of 1.5–4.0 μg/mL.
Additionally, cefoxitin MICs, after passages, range of
1.5–4.0 μg/mL and therefore, all isolates tested were
considered susceptible to cefoxitin.
Isolates Sa49, Sa26, Sa27 and Sa16 were grouped into
cluster E and related to USA400. The isolates Sa61 and
Sa64 exhibited the new ST2382 described. The OS-MRSA
isolate Sa03 was related to USA100/New York/Japan.
Isolates Sa12, Sa51, Sa29 and Sa87 were grouped into
cluster F and related to USA800/PC. The OS-MRSA
isolates Sa17, Sa77, Sa06 (ST333) and Sa38 (ST15) were
grouped into cluster G. Isolate Sa52 exhibited ST239 and
t037, similar to BEC clone and the isolates Sa34, Sa50,
Sa02 and Sa70 (ST30) were grouped into cluster H (Fig. 2).
Isolates Sa14 and Sa74 exhibited a faint PCR product band
for ccr genes and were not considered for the analysis.
The remaining 3 isolates were mecA negative, although
they harbored mec complex type A (Sa5 and Sa21) and ccr
gene type 5 (Sa56) (Fig. 2).
We observed clonal spread of MRSA and MSSA,
including OS-MRSA isolates, within the main hospital
analyzed (hospital 1). We also observed closely related
isolates between hospital 1 and all four isolates from
hospital 2 (Figs. 1 and 2), as well as hospital 3 (Sa83, 84,
85) (Fig. 2). Only 3 isolates (OS-MRSA) were untypeable
by PFGE, Sa4 (ST-nontypeable/t10550), Sa9 (ST-nontype-
able/t037) and Sa45 (ST398/t1451). These results were
confirmed by repeating running (PFGE), amplification and
sequencing (MLST and spa) at least five times.
Discussion
The BEC clone, first described in 1992 in Brazil, is a uni-
versally occurring multidrug-resistant linage, endemic in
Brazilian hospitals and predominant among HA-MRSA
in the country. This clone displays some characteristics
such as enhanced ability to produce biofilm, to adhere
to and invade epithelial airway cells that could provide a
great capacity for worldwide spread. In this context,
BEC is responsible for a large number of HA-MRSA in-
fections in several South American countries and in
other continents [10, 13, 28–30].
In this study, BEC was the most common MRSA clone
observed, representing 61 % of MRSA isolates. BEC
isolates are known to be dispersed throughout Brazil,
with a major clonal type being responsible for 70–80 %
of BEC strains [30, 31]. More recently, increased
variability in PFGE patterns for BEC isolates in Brazil
has been described [11]. Similarly, we observed extensive
variability of PFGE patterns for BEC isolates, suggesting
clonal divergence over time. This observation reinforces
the report of [11] that these genetic changes may have
some significance in a particular epidemiological sce-
nario and might correspond to an important instrument
of clonal divergence.
Few data have been published on the incidence of
MRSA and MSSA infection in Northeast Brazil. In one
study, BEC accounted for 70 % of MRSA strains from a
university general hospital in Recife during 2002–2003,
with 14 % of strains being USA800/PC -related [13].
USA800-related strains were also common in the
present study. All MRSA isolates carrying SCCmecIV
were considered to be related to USA800 and were the
second most frequent MRSA isolates found in Recife.
These isolates were in general more homogeneous than
BEC isolates by PFGE analysis. We also found several
MSSA isolates related to the USA800 clone.
Some authors have reported that type IV MRSA isolates
from different lineages can carry specific virulence factors
(as presence of egc locus, pvl and biofilm production) and/
or resistance genes [3, 13, 31, 32]. Thus, the USA800
isolates seems to have specific characteristics that give the
bacteria the ability to spread and promote their emergence
as important pathogen in hospital settings worldwide. The
isolates related to the peadiatric epidemic clone might
conserve features that provide more homogeneity to these
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isolates which could afford their maintenance in hospital
environment.
We describe one MRSA isolate (Sa81) related to the
USA100/New York/Japan clone, which was isolated from
the blood of a cardiology patient. Some studies in Brazil
have reported the presence of strains related to the
USA100, ST5 [13, 16, 33, 34]. A similar strain, USA100
with ST105, spa type t002, SCCmecII MRSA, was
reported from Southeast [35], suggesting that this clone
could be dispersed throughout the country.
We observed 30 MSSA isolates that carries the mecA
gene, without mec complex amplification, referred as
OS-MRSA. This phenomenon may occur by partial
excision of SCCmec in multiresistant MRSA isolates or
chromosomal integration of the cassette chromosome,
resulting in MSSA isolates that contain SCCmec
segments. Some studies have reported the presence of
resistance determinants in MSSA isolates [7, 35]. An
additional table file shows this in more detail (see
Additional file 1). According to CLSI [20], staphylo-
coccal isolates that carry the mecA gene or produce
PBP2a must be reported as oxacillin resistant in
hospital settings.
Results from Oliveira and de Lencastre [36] strongly
suggest that the transcriptional control of the mecA gene is
mediated either directly or indirectly by other yet unidenti-
fied determinants (other than system mecI-mecR1 from
mec complex), resulting in the phenotypic expression of β-
lactam resistance. Because testing for mecA and PBP2a is
not a routine procedure performed by clinical microbiol-
ogy laboratories in Brazil, clinical isolates could be misclas-
sified as MSSA and have implications for treatment of
patients with staphylococcal infection. It is important to
emphasize that the OS-MRSA isolates observed appears to
be genetically diverse. Some of them were related to
epidemic clones as USA400, USA100/New York/Japan,
USA800/PC and BEC. To our knowledge, this is the first
study of prevalence of OS-MRSA infections in Brazil.
Further research is required to better characterize the OS-
MRSA isolates observed. Studies are needed to evaluate
the epidemiology, virulence factors, dissemination and
implications for clinical treatment of OS-MRSA in Brazil.
Deurenberg and Stobberingh [28] described that the
transfer of the SCCmec to a MSSA lineage, with a com-
mon genetic background, possibly generated MRSA
clones such as CC5, CC8, CC22, CC30 and CC45. Thus,
either the acquisition or loss of SCCmec by MSSA and
MRSA isolates respectively may provide resistant or
susceptible isolates with similar genetic backgrounds,
conserving virulence characteristics, which might persist
simultaneously in the hospital environment and could
be responsible for nosocomial infection.
We observed various MSSA isolates related to epidemic
clones as the CA-MRSA USA400 and USA1100/SPW,
clones that are becoming common in hospitals worldwide
and are involved in many nosocomial infections [3]. In
general, the CA-MRSA are considered more virulent than
HA-MRSA due to the existence of several virulence
factors [37, 38]. USA1100 (SPW) was described for the
first time in Brazil in 2005 and continues to be de-
scribed in hospitals in Brazil, as well as the CA-MRSA
USA400, accounting for multiple types of medical
problems [18, 39].
We also verified MSSA isolates related to the HA-MRSA
USA800/PC, USA100/NY/J and USA600/BC. The Berlin
clone has the capacity of causing high mortality in patients
with MRSA bloodstream infections and has great capacity
for global dissemination; however, infections caused by this
clone remain scarce in Brazil [16, 17, 40, 41].
Conclusion
In the present study, despite the number of isolates ana-
lysed, the clonal spread of MRSA and MSSA, including
a high prevalence of oxacillin-susceptible mecA-positive
S. aureus, was observed within several areas of the major
hospital investigated (outpatient clinic, inpatient ward
and ICU). We also verified closely related isolates
between hospitals, suggesting a possible spread of these
strains in the hospital environment that could be
responsible for nosocomial infections. We documented
the presence of several MRSA clones, as well as new
MLST and spa types, that were responsible for severe
infections in hospitalized patients. Some uncommon
isolate genotypes were observed.
Our findings concerning the prevalence of OS-MRSA in
clinical settings underscore the need of genotypic tests, in
addition to phenotypic assays, to accurately identify
MRSA. Moreover, our data alert to the necessity for devel-
opment more effective strategies for epidemiological
control of S. aureus in order to avoid an increase of hos-
pital infections. Further studies are required to determine
the degree of OS-MRSA spread throughout Brazil.
Additional file
Additional file 1: Reports of oxacillin-susceptible mecA-positive
Staphylococcus aureus (OS-MRSA) worldwide. Table showing published
reports of resistance determinants in MSSA isolates (OS-MRSA) around
the world. (PDF 135 kb)
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